PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.52%
Positive revenue growth while 9843.T is negative. John Neff might see a notable competitive edge here.
4.09%
Positive gross profit growth while 9843.T is negative. John Neff would see a clear operational edge over the competitor.
-0.99%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1.75%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
23.00%
Positive net income growth while 9843.T is negative. John Neff might see a big relative performance advantage.
22.99%
Positive EPS growth while 9843.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
22.99%
Positive diluted EPS growth while 9843.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.00%
Slight or no buybacks while 9843.T is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.00%
Slight or no buyback while 9843.T is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
150.12%
10Y revenue/share CAGR 1.25-1.5x 9843.T's 116.39%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
55.30%
5Y revenue/share CAGR 1.25-1.5x 9843.T's 44.35%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
35.06%
3Y revenue/share CAGR 1.25-1.5x 9843.T's 31.07%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
182.20%
Net income/share CAGR above 1.5x 9843.T's 69.89% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
18.63%
5Y net income/share CAGR above 1.5x 9843.T's 10.53%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
27.20%
3Y net income/share CAGR above 1.5x 9843.T's 16.68%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
325.14%
10Y equity/share CAGR 1.25-1.5x 9843.T's 251.23%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
83.13%
5Y equity/share CAGR is in line with 9843.T's 77.90%. Walter Schloss would see parallel mid-term profitability and retention policies.
35.58%
3Y equity/share CAGR similar to 9843.T's 39.36%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
100.00%
10Y dividend/share CAGR at 50-75% of 9843.T's 161.82%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
118.18%
5Y dividend/share CAGR above 1.5x 9843.T's 44.00%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
118.18%
3Y dividend/share CAGR above 1.5x 9843.T's 24.14%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
12.35%
AR growth is negative/stable vs. 9843.T's 34.88%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
4.44%
Inventory growth well above 9843.T's 1.76%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
10.86%
Asset growth above 1.5x 9843.T's 3.56%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.19%
BV/share growth above 1.5x 9843.T's 1.74%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
218.26%
We have some new debt while 9843.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
5.27%
SG&A growth well above 9843.T's 1.94%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.